Skip to search formSkip to main contentSkip to account menu

BGB-283

Known as: BEIGENE-283, Begeine-283, BGB 283 
An inhibitor of the serine/threonine protein kinase B-raf (BRAF) and epidermal growth factor receptor (EGFR), with potential antineoplastic activity… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
In a phase I trial, BGB-283, which targets the RAF family of proteins, was found to be safe and tolerable-and effective-in… 
2016
2016
Background: BGB-283 is a novel inhibitor of the RAF dimer with potent and reversible inhibitory activities against RAF family… 
2016
2016
Liver cancer has the third highest mortality rate among all cancers in China and hepatocellular carcinoma (HCC) is the most… 
2015
2015
Mutation in K-RAS, which drives constitutive activation of the mitogen-activated protein kinase (MAPK) signaling pathway, is one… 
2012
2012
Parties generally enter into contractual relations with the sincere intention to fulfil all the obligations created in terms of… 
2004
2004
direkte operative Behandlung (Sympathektomie, Endarteriektomie u.a.) hatte mit 42,2 % etwas bessere Resultate und mit 12,2 % eine… 
1996
1996
SUMARIO: I. UTILIDAD PUBLICA E INTERÉS PUBLICO: APLICACIÓN DE ESTA TERMINOLOGÍA EN MATERIA DE ASOCIACIONES. 1. Asociaciones de…